UBX - Unity Biotechnology GAAP EPS of -$1.36 misses by $0.30
- Unity Biotechnology press release ( NASDAQ: UBX ): Q3 GAAP EPS of -$1.36 misses by $0.30 .
- The company believes that current cash, cash equivalents, and marketable securities of $103.9M are sufficient to fund operations into the first quarter of 2024.
For further details see:
Unity Biotechnology GAAP EPS of -$1.36 misses by $0.30